17th Annual WORLDSymposium™

February 8 - February 12
Loading Events
  • This event has passed.

This symposium is designed for basic, translational and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries related to lysosomal diseases and the clinical investigation of these advances.

Michaël Hocquemiller, Head of Non-Clinical Development, will present biomarker data from the ongoing AAVance clinical trial with LYS-SAF302 for the treatment of MPS IIIA (NCT03612869) during the Late-Breaking Science session to be held on Friday, Frebruary 12, 2021 at 1:00 PM (EST).



February 8
February 12


Virtual Meeting

Lysogene COVID-19 update

Get In Touch

Don’t hesitate to contact us if you need more help.

    Back to top